

[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
[ Mon, Jun 17th 2024
] - WOPRAI
Jasper Hellweg Maintained (VRTX) at Strong Buy with Increased Target to $550 on, Jun 17th, 2024
Jasper Hellweg of Argus Research, Maintained "Vertex Pharmaceuticals Incorporated" (VRTX) at Strong Buy with Increased Target from $465 to $550 on, Jun 17th, 2024.
Jasper has made no other calls on VRTX in the last 4 months.
There are 11 other peers that have a rating on VRTX. Out of the 11 peers that are also analyzing VRTX, 2 agree with Jasper's Rating of Hold. Following are those relevant analyst calls for the last 4 months
- Brian Abrahams of "RBC Capital" Maintained at Hold with Decreased Target to $421 on, Tuesday, June 11th, 2024
- Joseph Stringer of "Needham" Reiterated at Hold on, Tuesday, May 7th, 2024
These are the ratings of the 9 analyists that currently disagree with Jasper
- Evan Seigerman of "BMO Capital" Maintained at Buy with Increased Target to $500 on, Friday, May 31st, 2024
- Christopher Raymond of "Piper Sandler" Maintained at Buy with Increased Target to $456 on, Tuesday, May 7th, 2024
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $462 on, Tuesday, May 7th, 2024
- Debjit Chattopadhyay of "Guggenheim" Maintained at Strong Buy with Increased Target to $450 on, Thursday, April 18th, 2024
- Colin Bristow of "UBS" Maintained at Strong Buy with Decreased Target to $466 on, Wednesday, April 17th, 2024
- Hartaj Singh of "Oppenheimer" Maintained at Buy and Held Target at $500 on, Monday, April 15th, 2024
- Whitney Ijem of "Canaccord Genuity" Maintained at Strong Sell and Held Target at $371 on, Friday, April 12th, 2024
- Liisa Bayko of "Evercore ISI Group" Upgraded from Hold to Buy and Held Target at $438 on, Thursday, April 11th, 2024
- Olivia Brayer of "Cantor Fitzgerald" Reiterated at Buy and Held Target at $440 on, Tuesday, February 20th, 2024
Contributing Sources